person · Reporting owner

CULP H LAWRENCE JR

Disclosed activity across 4 companies

Tapewire entity: 11018
SEC CIK: 0001205247

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
DANAHER CORP /DE/DHR · Entity 2871	Director · President and CEO	July 18, 2014	July 22, 2014
GE HealthCare Technologies Inc.GEHC · Entity 1711	Director	May 07, 2026	May 12, 2026
GENERAL ELECTRIC COGE · Entity 2813	Director · Chairman and CEO	March 02, 2026	March 04, 2026
PRICE T ROWE GROUP INCTROW · Entity 3212	Director	April 27, 2018	April 30, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DANAHER CORP /DE/

Report date July 18, 2014 · Filed July 22, 2014

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy LLCs	512,199	Last balance in matching sequence After 2014-07-18 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2014-07-18 · Exercise / conversion · Acquired 55,770 · Balance 567,969 F1: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Row 2 · 2014-07-18 · Sale · Disposed 55,770 · Balance 512,199 F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2014. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.83 to 74.08, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. F1: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Row 3 · 2014-07-18 · Exercise / conversion · Acquired 55,770 · Balance 567,969 F1: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Row 4 · 2014-07-18 · Sale · Disposed 55,770 · Balance 512,199 F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2014. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.00 to 74.59, inclusive. F1: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp.
Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.84 · Expires 2016-02-27	IndirectBy LLCs	1,009,460	Reported balance After 2014-07-18 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2014-07-18 · Exercise / conversion · Disposed 111,540 · Balance 1,009,460 F5: Fifty percent of the reported options became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 27, 2006. F1: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp.
Common StockSEC Table I · non-derivative	Direct	739,569	Reported balance Holding disclosure · report date 2014-07-18 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 739,569
Common StockSEC Table I · non-derivative	IndirectBy GRAT	68,479	Reported balance Holding disclosure · report date 2014-07-18 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 68,479
Common StockSEC Table I · non-derivative	Indirect401(k)	3,881	Reported balance Holding disclosure · report date 2014-07-18 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 3,881

Filing footnotes · ownership attribution and instrument terms

F1: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2014.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.83 to 74.08, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.00 to 74.59, inclusive.

F5: Fifty percent of the reported options became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 27, 2006.

GE HealthCare Technologies Inc.

Report date May 07, 2026 · Filed May 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	Direct	20,442	Ending reported balance After 2026-05-07 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-05-07 · Grant · Acquired 3,586 · Balance 16,285 F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). F2: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Row 2 · 2026-05-07 · Grant · Acquired 4,157 · Balance 20,442 F2: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectBy holding company	151,207	Reported balance Holding disclosure · report date 2026-05-07 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 151,207
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	IndirectBy family trusts	328,268	Reported balance Holding disclosure · report date 2026-05-07 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 328,268

Filing footnotes · ownership attribution and instrument terms

F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

GENERAL ELECTRIC CO

Report date March 02, 2026 · Filed March 04, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	240,745	Ending reported balance After 2026-03-03 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-03-03 · Exercise / conversion · Acquired 14,872 · Balance 246,979 Row 2 · 2026-03-03 · Tax withholding · Disposed 6,234 · Balance 240,745
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	9,355	Reported balance After 2026-03-02 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-03-02 · Grant · Acquired 9,355 · Balance 9,355 F1: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. F2: The Restricted Stock Units and the Employee Stock Options were granted on March 2, 2026, and vest in two equal installments of 50% each, on the second and third anniversary.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-03-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2026-03-03 · Exercise / conversion · Disposed 14,872 · Balance 0 F1: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. F3: Reflects lapse of restrictions in accordance with the retirement eligibility provision of the grant agreement.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $345.74 · Expires 2036-03-02	Direct	32,665	Reported balance After 2026-03-02 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2026-03-02 · Grant · Acquired 32,665 · Balance 32,665 F2: The Restricted Stock Units and the Employee Stock Options were granted on March 2, 2026, and vest in two equal installments of 50% each, on the second and third anniversary.
Common StockSEC Table I · non-derivative	IndirectBy family trusts	999,624	Reported balance Holding disclosure · report date 2026-03-02 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 999,624
Common StockSEC Table I · non-derivative	IndirectBy holding company	211,210	Reported balance Holding disclosure · report date 2026-03-02 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 211,210

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock.

F2: The Restricted Stock Units and the Employee Stock Options were granted on March 2, 2026, and vest in two equal installments of 50% each, on the second and third anniversary.

F3: Reflects lapse of restrictions in accordance with the retirement eligibility provision of the grant agreement.

PRICE T ROWE GROUP INC

Report date April 27, 2018 · Filed April 30, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	8,942	Reported balance After 2018-04-27 transaction · row 1 1 source row Row 1 · 2018-04-27 · Grant · Acquired 1,755 · Balance 8,942 F1: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued at $114.02 per share, the closing price of TROW shares on April 27, 2018. The forfeiture provisions of the Award Shares and all accrued dividends attributed to such Award Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control.
Common StockSEC Table I · non-derivative	IndirectCulp Dynasty Trust	874	Reported balance Holding disclosure · report date 2018-04-27 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 874
Common StockSEC Table I · non-derivative	IndirectCulp Family Foundation	249	Reported balance Holding disclosure · report date 2018-04-27 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 249
Common StockSEC Table I · non-derivative	IndirectWendy H. Culp Revocable Trust	884	Reported balance Holding disclosure · report date 2018-04-27 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 884
Common StockSEC Table I · non-derivative	IndirectWinterset Lane, LLC	2,064	Reported balance Holding disclosure · report date 2018-04-27 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 2,064

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued at $114.02 per share, the closing price of TROW shares on April 27, 2018. The forfeiture provisions of the Award Shares and all accrued dividends attributed to such Award Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 07, 2026 Filed May 12, 2026 00:14 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	4,157	$0.00	$0.00	Disclosure SEC source: 0001205247-26-000008 · wk-form4_1778544891.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,442 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. Read SEC document
May 07, 2026 Filed May 12, 2026 00:14 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	3,586	$0.00	$0.00	Disclosure SEC source: 0001205247-26-000008 · wk-form4_1778544891.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,285 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document
May 06, 2026 Filed May 7, 2026 20:14 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	PurchaseCommon Stock, par value $0.01 per share	80,805	$61.88	$5,000,076.03	Disclosure SEC source: 0001205247-26-000006 · wk-form4_1778184869.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By holding company Disclosed balance after: 151,207 F1 · price: The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:15 UTC	GENERAL ELECTRIC CO GE · Entity 2813	Exercise / conversionRestricted Stock Units · Derivative	14,872	$0.00	$0.00	Disclosure SEC source: 0001205247-26-000004 · wk-form4_1772658912.xml · derivative · entry 7 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. F3 · date: Reflects lapse of restrictions in accordance with the retirement eligibility provision of the grant agreement. F3 · derivative.exercise_date: Reflects lapse of restrictions in accordance with the retirement eligibility provision of the grant agreement. F3 · derivative.expiration_date: Reflects lapse of restrictions in accordance with the retirement eligibility provision of the grant agreement. Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:15 UTC	GENERAL ELECTRIC CO GE · Entity 2813	Tax withholdingCommon Stock	6,234	$334.14	$2,083,028.76	Disclosure SEC source: 0001205247-26-000004 · wk-form4_1772658912.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,745 Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:15 UTC	GENERAL ELECTRIC CO GE · Entity 2813	Exercise / conversionCommon Stock	14,872	$0.00	$0.00	Disclosure SEC source: 0001205247-26-000004 · wk-form4_1772658912.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:15 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantEmployee Stock Option (right to buy) · Derivative	32,665	$0.00 Strike: $345.74	$0.00	Disclosure SEC source: 0001205247-26-000004 · wk-form4_1772658912.xml · derivative · entry 6 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,665 Underlying: Common Stock · 32,665 shares Expires 2036-03-02 F2 · derivative.exercise_date: The Restricted Stock Units and the Employee Stock Options were granted on March 2, 2026, and vest in two equal installments of 50% each, on the second and third anniversary. Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:15 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantRestricted Stock Units · Derivative	9,355	$0.00	$0.00	Disclosure SEC source: 0001205247-26-000004 · wk-form4_1772658912.xml · derivative · entry 5 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,355 Underlying: Common Stock · 9,355 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units and the Employee Stock Options were granted on March 2, 2026, and vest in two equal installments of 50% each, on the second and third anniversary. F2 · derivative.expiration_date: The Restricted Stock Units and the Employee Stock Options were granted on March 2, 2026, and vest in two equal installments of 50% each, on the second and third anniversary. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:08 UTC	GENERAL ELECTRIC CO GE · Entity 2813	Tax withholdingCommon Stock	169,539	$342.26	$58,026,418.14	Disclosure SEC source: 0001205247-26-000002 · wk-form4_1772572101.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,107 Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:08 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantCommon Stock	401,646	$0.00	$0.00	Disclosure SEC source: 0001205247-26-000002 · wk-form4_1772572101.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,646 F1 · security: Settlement of performance rights granted on March 1, 2023. Read SEC document
May 28, 2025 Filed May 30, 2025 21:26 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	3,583	$0.00	$0.00	Disclosure SEC source: 0001628280-25-028669 · wk-form4_1748640327.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,790 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F4 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. Read SEC document
May 28, 2025 Filed May 30, 2025 21:26 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	3,092	$0.00	$0.00	Disclosure SEC source: 0001628280-25-028669 · wk-form4_1748640327.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,207 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · balance_after: Reflects the transfer by the reporting person of 289,906 shares of GE HealthCare common stock to a family trust on September 23, 2024. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:12 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantEmployee Stock Option (right to buy) · Derivative	57,540	$0.00 Strike: $201.96	$0.00	Disclosure SEC source: 0000040545-25-000043 · wk-form4_1741209121.xml · derivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,540 Underlying: Common Stock · 57,540 shares Expires 2035-03-03 F2 · derivative.exercise_date: The Restricted Stock Units vest and the Employee Stock Options become exercisable in two equal installments of 50% each, on the second and third anniversary of the grant date. Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:12 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantRestricted Stock Units · Derivative	14,872	$0.00	$0.00	Disclosure SEC source: 0000040545-25-000043 · wk-form4_1741209121.xml · derivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,872 Underlying: Common Stock · 14,872 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest and the Employee Stock Options become exercisable in two equal installments of 50% each, on the second and third anniversary of the grant date. F2 · derivative.expiration_date: The Restricted Stock Units vest and the Employee Stock Options become exercisable in two equal installments of 50% each, on the second and third anniversary of the grant date. Read SEC document
August 17, 2024 Filed Aug 20, 2024 20:17 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	Tax withholdingCommon Stock, par value $0.01 per share	291,053	$84.80	$24,681,294.40	Disclosure SEC source: 0001628280-24-037895 · wk-form4_1724185041.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,021 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of performance shares originally granted by General Electric Company in 2020. Read SEC document
August 17, 2024 Filed Aug 20, 2024 20:16 UTC	GENERAL ELECTRIC CO GE · Entity 2813	Tax withholdingCommon Stock	873,160	$169.60	$148,087,936.00	Disclosure SEC source: 0000040545-24-000186 · wk-form4_1724184967.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998,051 F1 · shares: Withholding of shares of General Electric Company common stock to satisfy tax withholding obligations in connection with the vesting of performance shares granted in 2020. Read SEC document
May 21, 2024 Filed May 23, 2024 20:30 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	2,440	$0.00	$0.00	Disclosure SEC source: 0001628280-24-024961 · wk-form4_1716496211.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,074 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:50 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	Tax withholdingCommon Stock, par value $0.01 per share	31,290	$91.28	$2,856,151.20	Disclosure SEC source: 0001628280-24-009067 · wk-form4_1709679019.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,634 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:24 UTC	GENERAL ELECTRIC CO GE · Entity 2813	Tax withholdingCommon Stock	110,513	$158.10	$17,472,105.30	Disclosure SEC source: 0000040545-24-000046 · wk-form4_1709677436.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,871,211 Read SEC document
March 01, 2024 Filed Mar 5, 2024 22:24 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantCommon Stock	238,846	$0.00	$0.00	Disclosure SEC source: 0000040545-24-000046 · wk-form4_1709677436.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,981,724 F1 · security: Settlement of performance rights granted on March 1, 2021. Read SEC document
May 23, 2023 Filed May 25, 2023 20:31 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	3,584	$0.00	$0.00	Disclosure SEC source: 0001628280-23-019786 · wf-form4_168504665531452.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 584,543 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document
February 09, 2023 Filed Dec 29, 2023 23:00 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon Stock, par value $0.01 per share	68,381	$0.00	$0.00	Disclosure SEC source: 0001628280-23-042943 · wk-form4_1703890810.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 652,924 F1 · date: Inadvertently filed late due to an administrative error. F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs will settle on March 1, 2024. Read SEC document
January 23, 2023 Filed Mar 24, 2023 21:01 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	PurchaseCommon Stock, par value $0.01 per share	748	$69.26	$51,806.48	Disclosure SEC source: 0001205247-23-000002 · wf-form4_167969165363124.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By family trusts Disclosed balance after: 1,272 F1 · date: Filed late due to an administrative error. Read SEC document
January 03, 2023 Filed Jan 6, 2023 01:39 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantDeferred Fee Phantom Stock Units · Derivative	588	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-001103 · doc4.xml · derivative · entry 4 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588 Underlying: Common stock, par value $0.01 per share · 588 shares Expires not disclosed F4 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F5 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F5 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document
January 03, 2023 Filed Jan 6, 2023 01:39 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon stock, par value $0.01 per share	580,959	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-001103 · doc4.xml · nonDerivative · entry 3 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,959 F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · shares: Represents performance shares that will vest, subject to continued service conditions and accelerated vesting in certain circumstances, based upon a weighted-average of the highest average closing price of GE's common stock and GE HealthCare's common stock for any 30 consecutive trading days during the performance period from January 3, 2023 to August 17, 2025: one-third of the performance shares will be eligible to vest upon achieving a stock price equal to 150% (the "threshold target") of the average of the closing prices of GE's common stock over the period of 30 consecutive trading days up to and including August 18, 2020 (the "30-day average price"), two-thirds of the performance shares will be eligible to vest upon achieving a stock price equal to 200% of the 30-day average price and all of the performance shares will be eligible to vest upon achieving a stock price equal to 250% (the "maximum target") of the 30-day average price. F3 · shares: No performance shares will vest below the threshold target, and the amount of performance shares that vest between the threshold target and maximum target will be determined by linear interpolation. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document
January 03, 2023 Filed Jan 6, 2023 01:39 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon stock, par value $0.01 per share	524	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-001103 · doc4.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trusts Disclosed balance after: 524 F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document
January 03, 2023 Filed Jan 6, 2023 01:39 UTC	GE HealthCare Technologies Inc. GEHC · Entity 1711	GrantCommon stock, par value $0.01 per share	70,403	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-001103 · doc4.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 70,403 F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document
May 02, 2022 Filed May 2, 2022 23:55 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	21,978	$75.26	$1,654,064.28	Disclosure SEC source: 0001062993-22-011309 · form4.xml · nonDerivative · entry 4 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 211,210 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $75.00 to $75.82, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
May 02, 2022 Filed May 2, 2022 23:55 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	24,629	$74.63	$1,838,062.27	Disclosure SEC source: 0001062993-22-011309 · form4.xml · nonDerivative · entry 3 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 189,232 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $74.03 to $74.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
May 02, 2022 Filed May 2, 2022 23:55 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	16,455	$73.60	$1,211,088.00	Disclosure SEC source: 0001062993-22-011309 · form4.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 164,603 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $73.01 to $73.97, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
May 02, 2022 Filed May 2, 2022 23:55 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	1,938	$72.80	$141,086.40	Disclosure SEC source: 0001062993-22-011309 · form4.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 148,148 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $72.69 to $72.98, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
August 18, 2020 Filed Aug 20, 2020 20:32 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantCommon Stock	13,943,028	$0.00	$0.00	Disclosure SEC source: 0000950142-20-002073 · es2001096_4-culp.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,943,028 F1 · shares: Represents performance shares that will vest, subject to continued employment conditions and accelerated vesting in certain circumstances, based upon the highest average closing price of the company's stock for any 30 consecutive trading days during the five-year performance period from August 18, 2020 to August 17, 2025: one-third of the performance shares will be eligible to vest upon achieving a stock price equal to 150% (the "threshold target") of the average of the closing prices of the company's stock over the period of 30 consecutive trading days up to and including the grant date (the "30-day average price"), two-thirds of the performance shares will be eligible to vest upon achieving a stock price equal to 200% of the 30-day average price and all of the performance shares will be eligible to vest upon achieving a stock price equal to 250% (the "maximum target") of the 30-day average price. F2 · shares: No performance shares will vest below the threshold target, and the amount of performance shares that vest between the threshold target and maximum target will be determined by linear interpolation. Read SEC document
August 15, 2019 Filed Aug 15, 2019 20:58 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	252,200	$7.93	$1,999,946.00	Disclosure SEC source: 0001231205-19-000165 · edgar.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 1,169,684 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $7.73 to $8.11, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
August 12, 2019 Filed Aug 13, 2019 10:47 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	331,684	$9.04	$2,998,423.36	Disclosure SEC source: 0001231205-19-000160 · edgar.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 930,076 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $9.03 to $9.05, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
December 31, 2018 Filed Jan 3, 2019 22:28 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantPerformance Stock Unit · Derivative	5,000,000	$0.00	$0.00	Disclosure SEC source: 0001231205-19-000002 · edgar.xml · derivative · entry 3 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Represents an inducement award of performance stock units ("PSUs"), granted outside the 2007 Long-Term Incentive Plan, to the reporting person in connection with his appointment as Chairman and CEO. Subject to continued employment conditions and accelerated vesting in certain circumstances, the PSUs will vest, if at all, based upon meeting the following stock performance conditions for 30 consecutive trading days during the four-year performance period from October 1, 2018 to September 30, 2022: half of the PSUs will be eligible to vest upon achieving a stock price of $18.60 (the "threshold target"), all of the PSUs will be eligible to vest upon achieving a stock price of $24.80, and an additional 2.5 million PSUs will be eligible to vest upon achieving a stock price of $31.00 (the "maximum target"). No PSUs will be granted below the threshold target, and the amount of PSUs granted between the threshold target and maximum target will be determined by linear interpolation. F2 · derivative.expiration_date: Represents an inducement award of performance stock units ("PSUs"), granted outside the 2007 Long-Term Incentive Plan, to the reporting person in connection with his appointment as Chairman and CEO. Subject to continued employment conditions and accelerated vesting in certain circumstances, the PSUs will vest, if at all, based upon meeting the following stock performance conditions for 30 consecutive trading days during the four-year performance period from October 1, 2018 to September 30, 2022: half of the PSUs will be eligible to vest upon achieving a stock price of $18.60 (the "threshold target"), all of the PSUs will be eligible to vest upon achieving a stock price of $24.80, and an additional 2.5 million PSUs will be eligible to vest upon achieving a stock price of $31.00 (the "maximum target"). No PSUs will be granted below the threshold target, and the amount of PSUs granted between the threshold target and maximum target will be determined by linear interpolation. Read SEC document
November 01, 2018 Filed Nov 5, 2018 12:14 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	225,000	$9.73	$2,189,250.00	Disclosure SEC source: 0001231205-18-000153 · edgar.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 585,800 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $9.55 to $9.90, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
October 01, 2018 Filed Oct 3, 2018 20:12 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantDeferred Fee Phantom Stock Units · Derivative	7,724	$12.30	$95,005.20	Disclosure SEC source: 0001231205-18-000145 · edgar.xml · derivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,826 Underlying: Common Stock · 7,724 shares Expires not disclosed F1 · security: Reflects payments for service as a director during the quarter ended September 30, 2018. F2 · security: Acquired at a price of $12.30 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F3 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F4 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F4 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document
July 24, 2018 Filed Jul 25, 2018 20:30 UTC	GENERAL ELECTRIC CO GE · Entity 2813	PurchaseCommon Stock	191,000	$13.04	$2,490,640.00	Disclosure SEC source: 0001231205-18-000088 · edgar.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By holding company Disclosed balance after: 360,800 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $12.92 to $13.12, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document
July 02, 2018 Filed Jul 3, 2018 19:48 UTC	GENERAL ELECTRIC CO GE · Entity 2813	GrantDeferred Fee Phantom Stock Units · Derivative	6,102	$13.52	$82,499.04	Disclosure SEC source: 0001231205-18-000081 · edgar.xml · derivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,102 Underlying: Common Stock · 6,102 shares Expires not disclosed F1 · security: Acquired at a price of $13.52 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document
April 27, 2018 Filed Apr 30, 2018 20:37 UTC	PRICE T ROWE GROUP INC TROW · Entity 3212	GrantCommon Stock	1,755	$0.00	$0.00	Disclosure SEC source: 0001127602-18-015575 · form4.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,942 F1 · shares: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued at $114.02 per share, the closing price of TROW shares on April 27, 2018. The forfeiture provisions of the Award Shares and all accrued dividends attributed to such Award Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document
April 27, 2017 Filed Apr 28, 2017 17:47 UTC	PRICE T ROWE GROUP INC TROW · Entity 3212	GrantCommon Stock	2,837	$0.00	$0.00	Disclosure SEC source: 0001127602-17-015832 · form4.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 F1 · shares: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Award Shares was issued at $70.52 per share, the closing price of TROW shares on April 27, 2017. The forfeiture provisions of the Award Shares and all accrued dividends attributed to such Award Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document
November 01, 2016 Filed Nov 3, 2016 14:08 UTC	PRICE T ROWE GROUP INC TROW · Entity 3212	GrantStock Options (Right to Buy) · Derivative	4,350	$0.00 Strike: $63.82	$0.00	Disclosure SEC source: 0001127602-16-065950 · form4.xml · derivative · entry 6 CULP H LAWRENCE JR · CIK 0001205247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,350 Underlying: Common Stock · 4,350 shares Expires 2026-11-01 F1 · derivative.exercise_date: Pursuant to the Amended and Restated 2007 Non-Employee Director Equity Plan, this stock option was issued at $63.82 per share, the closing price of TROW shares on November 1, 2016. The forfeiture provisions of the this award will vest upon the earliest of the following: (a) one year after the date of award, (b) the day immediately prior to the annual meeting of stockholders of the Company at which members of the Board of Directors are to be elected that occurs in the next calendar year following the year in which the date of award occurs, (c) death or (d) immediately before and contingent upon the occurrence of a Change in Control. Read SEC document
July 18, 2014 Filed Jul 22, 2014 21:18 UTC	DANAHER CORP /DE/ DHR · Entity 2871	Exercise / conversionEmployee stock option (right to buy) · Derivative	111,540	$0.00 Strike: $30.84	$0.00	Disclosure SEC source: 0000313616-14-000092 · edgar.xml · derivative · entry 8 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 1,009,460 Underlying: Common Stock · 111,540 shares Expires 2016-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fifty percent of the reported options became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 27, 2006. F1 · ownership.nature: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Read SEC document
July 18, 2014 Filed Jul 22, 2014 21:18 UTC	DANAHER CORP /DE/ DHR · Entity 2871	SaleCommon Stock	55,770	$74.27	$4,141,982.13	Disclosure SEC source: 0000313616-14-000092 · edgar.xml · nonDerivative · entry 4 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 512,199 F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2014. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.00 to 74.59, inclusive. F1 · ownership.nature: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Read SEC document
July 18, 2014 Filed Jul 22, 2014 21:18 UTC	DANAHER CORP /DE/ DHR · Entity 2871	Exercise / conversionCommon Stock	55,770	$30.84	$1,719,946.80	Disclosure SEC source: 0000313616-14-000092 · edgar.xml · nonDerivative · entry 3 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 567,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Read SEC document
July 18, 2014 Filed Jul 22, 2014 21:18 UTC	DANAHER CORP /DE/ DHR · Entity 2871	SaleCommon Stock	55,770	$74.01	$4,127,258.85	Disclosure SEC source: 0000313616-14-000092 · edgar.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 512,199 F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.83 to 74.08, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. F1 · ownership.nature: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Read SEC document
July 18, 2014 Filed Jul 22, 2014 21:18 UTC	DANAHER CORP /DE/ DHR · Entity 2871	Exercise / conversionCommon Stock	55,770	$30.84	$1,719,946.80	Disclosure SEC source: 0000313616-14-000092 · edgar.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By LLCs Disclosed balance after: 567,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Owned by limited liability companies (the "LLCs"), as to each of which the members are Mr. Culp and an entity controlled by Mr. Culp. Read SEC document
July 08, 2014 Filed Jul 8, 2014 22:49 UTC	DANAHER CORP /DE/ DHR · Entity 2871	GrantCommon Stock	123,990	$0.00	$0.00	Disclosure SEC source: 0000313616-14-000070 · edgar.xml · nonDerivative · entry 1 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 739,569 F1 · shares: On February 21, 2013, the Compensation Committee of the Company's Board of Directors awarded the reporting person performance based restricted stock units. This Form 4 is being filed in connection with the determination by the Compensation Committee that the performance criteria of the award have been achieved. The award remains subject to time-based vesting provisions. Read SEC document
February 25, 2014 Filed Feb 26, 2014 13:20 UTC	DANAHER CORP /DE/ DHR · Entity 2871	Tax withholdingCommon Stock	29,747	$76.82	$2,285,164.54	Disclosure SEC source: 0000313616-14-000034 · edgar.xml · nonDerivative · entry 2 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615,579 F1 · kind: The transaction reported in this Form 4 relates to the withholding of certain shares for tax purposes in connection with the vesting of performance-based restricted stock units. Read SEC document
February 24, 2014 Filed Feb 26, 2014 13:20 UTC	DANAHER CORP /DE/ DHR · Entity 2871	GrantEmployee stock option (right to buy) · Derivative	250,070	$0.00 Strike: $76.56	$0.00	Disclosure SEC source: 0000313616-14-000034 · edgar.xml · derivative · entry 6 CULP H LAWRENCE JR · CIK 0001205247 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,070 Underlying: Common Stock · 250,070 shares Expires 2024-02-24 F3 · derivative.exercise_date: Fifty percent of the options granted vest on each of the fourth and fifth anniversaries of the grant date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.